Every three minutes, someone in the UK is diagnosed with dementia. It is not an easy diagnosis to receive for the patient or ...
New research suggests THC’s cognitive drawbacks may be mitigated when combined with a targeted anti-inflammatory drug. Cannabis research has highlighted a scientific paradox. Its best-known ...
Morning Overview on MSN
Marijuana compound and cheap pain pill team up to stop Alzheimer’s
Alzheimer’s disease has long resisted simple solutions, but a new line of research suggests an unexpected pairing could help keep the condition at bay: a marijuana-derived compound working alongside a ...
Migraine Again on MSN
Nurtec ODT: FDA approved as the only migraine medication for prevention and acute treatment
Discover how rimegepant (Nurtec ODT) works for both migraine treatment and prevention. Learn about the approved age range, dosage, and how long it takes to see results.
By 2050, two million people will be living with dementia in the UK, experts have predicted following a surge in cases.
The family were told of her diagnosis of CLN2 Battens Disease, a type of childhood dementia, on March 26, 2024, as James ...
Find out about the innovations in dementia treatment, particularly new therapies that target Alzheimer's disease and improve quality of life.
HOLLY Nayler was just days away from her third birthday when she suffered her first seizure. It was the earliest sign of a rare form of childhood dementia, a disease doctors would later diagnose ...
NEW YORK (AP) _ Shares of Axovant Sciences nearly doubled in value after the dementia drug developer said its initial public offering raised $315 million, more than Axovant had expected. The offering ...
Tammy McDaid, from Swansea, said that instead of waking up excited to celebrate Tate's birthday, she had a panic attack because she knows the clock is ticking for him. He has Sanfilippo Syndrome - a ...
Researchers have developed smart nanoparticles that can seek out and destroy disease-causing proteins the body can’t normally eliminate. Unlike traditional drugs, these particles can reach ...
Researchers at the new Center for Brain Health at UT Health San Antonio are studying midlife testing for early-onset dementia with blood-based biomarkers to see if they can detect disease activity up ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results